By Ahmed El-Medany Presented at ESC 2021 by Dr. Judit Simon, of the Heart and Vascular Centre, Semmelweis University, Budapest, Hungary; this large study included…
View More A coffee a day keeps the doctor away?
Tag: Cardiovascular Risk
Plant‐Centered Diet is associated with a lower risk of Cardiovascular Disease
By Y Choi et alTaken directly from the Journal of the American Heart Association The study expands on previous studies by exploring the time‐varying relationship…
View More Plant‐Centered Diet is associated with a lower risk of Cardiovascular Disease
Clinical outcome of COVID-19 in patients with adult congenital heart disease
By Saadia Aslam Original research from Professor Markus Schwerzmann and his team collected clinical outcome data to help identify risk factors for a complicated course…
View More Clinical outcome of COVID-19 in patients with adult congenital heart disease
Artificial Intelligence, precision phenotyping and risk prediction in cardiomyopathy
By Ahmed El-Medany Presented by Prof O’Regan, MRC Investigator and Consultant Radiologist, Imperial College London The Digital Innovation in Cardiology session at BCS 2021 was…
View More Artificial Intelligence, precision phenotyping and risk prediction in cardiomyopathy
Obesity increases risk of cardiovascular complications in pregnant women with heart disease
By Saadia Aslam Adverse CE during pregnancy were examined in a prospective cohort of women with heart disease. CE were a composite of the following:…
View More Obesity increases risk of cardiovascular complications in pregnant women with heart disease
Leading cardiovascular organisations call for urgent action to reduce air pollution
“Even before the COVID-19 pandemic, air pollution was an issue of growing concern due to its impact on people’s health, although it was frequently overlooked…
View More Leading cardiovascular organisations call for urgent action to reduce air pollution
Erythromycin: Caution required due to cardiac risks (QT interval prolongation); drug interaction with rivaroxaban
Drug Safety Update Published 17 December 2020From: Medicines and Healthcare products Regulatory Agency Erythromycin has been associated with events secondary to QT interval prolongation such…
View More Erythromycin: Caution required due to cardiac risks (QT interval prolongation); drug interaction with rivaroxaban
COVID-19: Disentangling Ethnicity and Cardiovascular Risk
BCS Editorial By Ashwin Ajay and Ahmed Adlan Pneumonia of unknown cause began spreading in Wuhan, China, in late 2019, which led to the discovery…
View More COVID-19: Disentangling Ethnicity and Cardiovascular Risk